Activation of inflammasome by attenuated Salmonella typhimurium in bacteria-mediated cancer therapy

Microbiology and Immunology

Volumn 59, Issue 11, 2015, Pages 664-675

  Phan, Thuy Xuan ^a   Nguyen, Vu Hong ^a   Duong, Mai Thi Quynh ^a   Hong, Yeongjin ^a   Choy, Hyon E ^a   Min, Jung Joon ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

IL 1 ; Inflammasome; Salmonella typhimurium

Indexed keywords

ADENOSINE TRIPHOSPHATE; BACTERIAL PROTEIN; CASPASE 12; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; PROBIOTIC AGENT; PROTEIN IPAF; PROTEIN P10; PURINERGIC P2X7 RECEPTOR; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BONE MARROW DERIVED MACROPHAGE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CANCER THERAPY; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SIGNAL TRANSDUCTION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; ESCHERICHIA COLI; HUMAN; IMMUNOLOGY; MACROPHAGE; NEOPLASMS; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; ESCHERICHIA COLI; HUMANS; INFLAMMASOMES; MACROPHAGES; MICE; MICE, INBRED C57BL; NEOPLASMS; SALMONELLA TYPHIMURIUM;

EID: 84948127709     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12333     Document Type: Article

References (38)

1. Coely W.B. (1894) Treatment of inoperable malignant tumors with the toxines of erysipelas and the bacillus prodigiosus. Am J Med Sci 108: 50-66.
2. Forbes N.S. (2010) Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer 10: 785-94.
3. Min J.J., Kim H.J., Park J.H., Moon S., Jeong J., Hong Y.J., Cho K.O., Nam J., Kim N., Park Y.K., Bom H.S., Rhee J., Choy H.E. (2008) Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli. Mol Imaging Biol 10: 54-61.
4. Nguyen V.H., Kim H.S., Ha J.M., Hong Y., Choy H.E., Min J.J. (2010) Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer. Cancer Res 70: 18-23.
5. Jiang S.N., Phan T.X., Nam T.K., Nguyen V.H., Kim H.S., Bom H.S., Choy H.E., Hong Y., Min J.J. (2010) Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy. Mol Ther 18: 635-42.
6. Jeong J.H., Kim K., Lim D., Jeong K., Hong Y., Nguyen V.H., Kim T.H., Ryu S., Lim J.A., Kim J.I., Kim G.J., Kim S.C., Min J.J., Choy H.E. (2014) Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium. PLoS ONE 9: e80050.
7. Jiang S.N., Park S.H., Lee H.J., Zheng J.H., Kim H.S., Bom H.S., Hong Y., Szardenings M., Shin M.G., Kim S.C., Ntziachristos V., Choy H.E., Min J.J. (2013) Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent. Mol Ther 21: 1985-95.
8. Kim K., Jeong J.H., Lim D., Hong Y., Yun M., Min J.J., Kwak S.J., Choy H.E. (2013) A novel balanced-lethal host-vector system based on glmS. PLoS ONE 8: e60511.
9. Min J.J., Nguyen V.H., Kim H.J., Hong Y., Choy H.E. (2008) Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals. Nat Protoc 3: 629-736.
10. Park S.J., Park S.H., Cho S., Kim D.M., Lee Y., Ko S.Y., Hong Y., Choy H.E., Min J.J., Park J.O., Park S. (2013) New paradigm for tumor theranostic methodology using bacteria-based microrobot. Sci Rep 3: 3394.
11. Theys J., Nuyts S., Landuyt W., Van Mellaert L., Dillen C., Böhringer M., Dürre P., Lambin P., Anné J. (1999) Stable Escherichia coli-Clostridium acetobutylicum shuttle vector for secretion of murine tumor necrosis factor alpha. Appl Environ Microbiol 65: 4295-300.
12. Reisser D., Pance A., Jeannin J.-F. (2002) Mechanisms of the antitumoral effect of lipid A. BioEssays 24: 284-9.
13. Leschner S., Westphal K., Dietrich N., Viegas N., Jablonska J., Lyszkiewicz M., Lienenklaus S., Falk W., Gekara N., Loessner H., Weiss S. (2009) Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha. PLoS ONE 4: e6692.
14. Kim J.E., Phan T.X., Nguyen V.H., Dinh-Vu H.V., Zheng J.H., Yun M., Park S.G., Hong Y., Choy H.E., Szardenings M., Hwang W., Park J.A., Park S., Im S.H., Min J.J. (2015) Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics 5: 1328-42.
15. Netea M.G., Simon A., van de Veerdonk F., Kullberg B.J., Van der Meer J.W.M., Joosten L.A.B. (2010) IL-1β processing in host defense: beyond the inflammasomes. PLoS Pathog 6: e1000661.
16. Franchi L., Munoz-Planillo R., Nunez G. (2012) Sensing and reacting to microbes through the inflammasomes. Nat Immunol 13: 325-32.
17. Franchi L., Amer A., Body-Malapel M., Kanneganti T.D., Ozoren N., Jagirdar R., Inohara N., Vandenabeele P., Bertin J., Coyle A., Grant E.P., Nunez G. (2006) Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 7: 576-82.
18. Miao E.A., Mao D.P., Yudkovsky N., Bonneau R., Lorang C.G., Warren S.E., Leaf I.A., Aderem A. (2010) Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci USA 107: 3076-80.
19. Aymeric L., Apetoh L., Ghiringhelli F., Tesniere A., Martins I., Kroemer G., Smyth M.J., Zitvogel L. (2010) Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res 70: 855-8.
20. Shimada K., Crother T.R., Karlin J., Dagvadorj J., Chiba N., Chen S., Ramanujan V.K., Wolf A.J., Vergnes L., Ojcius D.M., Rentsendorj A., Vargas M., Guerrero C., Wang Y., Fitzgerald K.A., Underhill D.M., Town T., Arditi M. (2012) Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36: 401-14.
21. Ayna G., Krysko D.V., Kaczmarek A., Petrovski G., Vandenabeele P., Fésüs L. (2012) ATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophages. PLoS ONE 7: e40069.
22. Perregaux D.G., Gabel C.A. (1994) Interleukin-1 beta maturation and release in response to ATP and nigericin. J Biol Chem 269: 15, 195-203.
23. Mariathasan S., Monack D.M. (2007) Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 7: 31-40.
24. De Nardo D., Latz E. (2011) NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol 32: 373-9.
25. Davis B.K., Wen H., Ting J.P.Y. (2011) The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 29: 707-35.
26. Cook G.P., Savic S., Wittmann M., McDermott M.F. (2010) The NLRP3 inflammasome, a target for therapy in diverse disease states. Eur J Immunol 40: 631-4.
27. Ferrari D., Pizzirani C., Adinolfi E., Lemoli R.M., Curti A., Idzko M., Panther E., Di Virgilio F. (2006) The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176: 3877-83.
28. Elliott J.A., Winn W.C. (1986) Treatment of alveolar macrophages with cytochalasin D inhibits uptake and subsequent growth of Legionella pneumophila. Infect Immun 51: 31-6.
29. Trautmann A. (2009) Extracellular ATP in the Immune System: More Than Just a "Danger Signal". Sci Signal 2: pe6.
30. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., Lee W.P., Weinrauch Y., Monack D.M., Dixit V.M. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-32.
31. Di Virgilio F. (2007) Liaisons dangereuses: P2X7 and the inflammasome. Trends Pharmacol Sci 28: 465-72.
32. Song M., Kim H.J., Kim E.Y., Shin M., Lee H.C., Hong Y., Rhee J.H., Yoon H., Ryu S., Lim S., Choy H.E. (2004) ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. J Biol Chem 279: 34, 183-90.
33. Sun Y.H., Rolán H.G., Tsolis R.M. (2007) Injection of flagellin into the host cell cytosol by Salmonella enterica serotype Typhimurium. J Biol Chem 282: 33, 897-901.
34. Vijay-Kumar M., Carvalho F.A., Aitken J.D., Fifadara N.H., Gewirtz A.T. (2010) TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin. Eur J Immunol 40: 3528-34.
35. Netea M.G., Kullberg B.J., Joosten L.A.B., Sprong T., Verschueren I., Boerman O.C., Amiot F., van den Berg W.B., Van der Meer J.W.M. (2001) Lethal Escherichia coli and Salmonella typhimurium endotoxemia is mediated through different pathways. Eur J Immunol 31: 2529-38.
36. Winfield M.D., Groisman E.A. (2004) Phenotypic differences between Salmonella and Escherichia coli resulting from the disparate regulation of homologous genes. Proc Natl Acad Sci USA 101: 17, 162-67.
37. Schroder K., Tschopp J. (2010) The Inflammasomes. Cell 140: 821-32.
38. Petrilli V., Papin S., Dostert C., Mayor A., Martinon F., Tschopp J. (2007) Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14: 1583-9.